샘플 요청 목록

 카트 문의
시장보고서
상품코드
1858792

세계의 플레이버 동물 의약품 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

Flavored Veterinary Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

플레이버 동물 의약품 시장 규모는 2024년에 35억 7,300만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 9.3%로 성장하여 2031년까지 66억 100만 달러에 달할 것으로 예측됩니다.

가향 동물용의약품은 특정 향료, 미각 마스킹제 또는 투여 형태를 개선한 제제를 사용하여 제조된 동물용의약품을 말합니다. 이는 자발적 복용량과 치료 순응도를 높여 임상 결과와 복약 경험을 개선하는 것을 목표로 하고 있습니다. 이 제품들은 반려동물(개, 고양이, 조류 등) 및 일부 사육 가축을 대상으로 하며, 처방약과 일반의약품 모두 향이 첨가된 경구용 정제, 츄어블 정제, 액상, 현탁액, 사료 혼합 제제 등을 포함합니다. 향료 첨가는 동물이 본래 가지고 있는 혐오감(쓴맛, 이취, 불쾌한 식감 등)을 극복하는 것을 목적으로 하며, 종별에 따른 기호성(예: 육류, 생선 선호도)과 식감의 최적화를 통해 투여의 단순화, 스트레스 감소, 치료 과정의 완료율 향상을 도모합니다. 향료 첨가 외에도 현대의 향료 동물용 의약품은 투여 시스템과의 시너지 효과와 투여 편의성(츄어블 정제, 구강 페이스트, 프리믹스 사료)을 중시하고 동물과 인간의 먹이 사슬의 안전을 보호하기 위해 엄격한 안전, 잔류물 및 수의학 규제 표준을 준수해야합니다.

반려동물 사육률 증가, 반려동물의 인간화, 반려동물 의료비 증가로 인해 약물 순응도 향상, 동물의 스트레스 감소, 치료 완료율 향상을 위한 실용적인 솔루션으로 수의학 향료 의약품에 대한 수요가 증가하고 있습니다. 주요 동물용 의약품 기업의 연례 보고서에 따르면, 제품 포트폴리오 확장, M&A, 지역적 성장을 통해 기호성과 제형 기술을 핵심 전략에 통합하고 있습니다. 허용되는 제형 및 기호성 주장에 대한 규정이 명확해짐에 따라 규정 준수의 길이 더욱 명확해졌습니다. 향료 기술(마이크로 캡슐화, 서방형)의 발전으로 향료의 지속성과 안전성이 향상되어 만성 치료 및 장기 투여에 적합한 제품이 가능해졌고, 기호성 혁신이 성장의 핵심 원동력이 되고 있습니다.

주요 제약 요인으로는 허가된 향료 화합물, 첨가제 잔류물, 인체 식품 안전에 미치는 영향에 대한 규제 당국의 감시를 들 수 있으며, 기업은 연례 보고서에 공개되는 컴플라이언스 비용과 혁신의 균형을 맞추어야 합니다. 향료와 첨가제의 상호작용은 약물의 안정성과 생체 이용률에 영향을 미칠 수 있으며, 고비용의 적합성 시험과 독성 시험이 필수적입니다. 처방약 및 조제 제품에 대한 규제 모호성과 조제에 대한 감시 강화는 소규모 조제 약국 및 수의사 조제 모델에 혼란을 초래할 수 있습니다. 마지막으로, 기존 수의약품 대기업 및 전문 향료 공급업체와의 경쟁으로 인해 중소기업의 이익률이 압박을 받을 수 있습니다.

다운스트림에서는 수요가 순수한 기능적 선호에서 상황에 따른 서비스 지향적 요구로 전환되고 있습니다. 반려동물 보호자와 수의사는 투약 편의성, 스트레스 감소, 재택 진료에 대한 적합성을 요구하고 있습니다. 이에 따라 편리한 제형(일회용 구강 스트립, 츄어블 정제, 츄어블 액상), 다양한 맛 포트폴리오, 연령, 품종, 기호에 맞는 솔루션에 대한 수요가 증가하고 있습니다. 식품 안전과 공중 보건의 관점에서 볼 때, 축산 분야에서는 기호성과 잔류물 관리의 균형을 갖춘 안전하고 혼합 가능한 향료 솔루션이 요구되고 있습니다. 임상 가이드라인과 기업 연례 보고서의 전략적 노력은 표준화되고 확장 가능한 향이 첨가된 동물용 의약품에 대한 수요 증가를 시사하고 있습니다.

주요 업스트림 공정 투입물에는 천연 또는 합성 향미 화합물, 감미료, 맛 마스킹제, 식감 조절용 부형제 및 결합제, 의약품 활성 성분과 호환되는 담체 및 안정제 등이 포함됩니다. 향료 재료와 유효성분의 물리화학적 적합성, 안정성, 독성학적 안전성 확보가 과제입니다. 또한 원료의 변동성, 공급업체 집중, 수출입 규제(특히 천연추출물)로 인한 공급 리스크도 존재합니다. 지속가능성과 책임 있는 조달도 중요합니다. 천연 향료 원료는 기후 변화의 영향을 받기 쉬우며, 합성 대체품은 안전성과 수용성 기준을 충족해야 합니다. 주요 동물용의약품 기업들은 연례 보고서에서 공급업체 선정 기준, 원료 추적성, GMP 준수 첨가제 조달 등 비용과 시장 진입 장벽을 동시에 높이는 요소의 중요성을 강조하고 있습니다. 본 제품의 매출총이익률은 약 55%입니다.

이 보고서는 수의용 향료 의약품 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

동물용 향료 의약품 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 매출액으로 제시되었습니다. 정량적, 정성적 분석을 통해 독자들이 수의용 향료 의약품의 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

  • Boehringer Ingelheim
  • Elanco Animal Health
  • Zoetis
  • Merck & Co.
  • Ceva
  • Vetoquinol
  • Wedgewood Pharmacy
  • Virbac
  • BOVA
  • Lee Silsby Compounding Pharmacy
  • Golden Gate
  • China Animal Healthcare
  • Qingdao Yibang
  • Rupu Bio

유형별 부문

  • 고기 풍미
  • 생선 풍미
  • 과일 풍미
  • 기타

용도별 부문

  • 개
  • 고양이
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
LSH 25.11.25

The global market for Flavored Veterinary Medication was estimated to be worth US$ 3573 million in 2024 and is forecast to a readjusted size of US$ 6601 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.

Flavored veterinary medication refers to animal medicinal products formulated with specific flavoring agents, taste-masking excipients, or modified dosage forms designed to enhance voluntary intake and treatment adherence, thereby improving clinical outcomes and the medication experience. These products span companion animals (dogs, cats, birds, etc.) and some confined livestock, and include flavored oral tablets, chewables, liquids, suspensions, and feed-mix formulations, both prescription and OTC. Flavoring aims to overcome animals' innate aversions-bitterness, off-odors or unpleasant textures-by using species-targeted flavors (e.g., meat, fish preferences) and textural optimization to simplify administration, reduce stress, and increase completion rates of therapeutic courses. Beyond flavor addition, modern flavored veterinary medicines emphasize synergy with delivery systems and dosage convenience (chewables, oral pastes, premixed feed), and must comply with strict safety, residue and veterinary regulatory standards to protect both animal and human food-chain safety.

Rising pet ownership, pet humanization, and upgraded pet healthcare spending drive demand for flavored veterinary medications as practical solutions to improve adherence, reduce animal stress, and improve therapeutic completion. Corporate annual reports indicate that major animal-health companies are integrating palatability and formulation capabilities into core strategies through product portfolio expansion, M&A and geographic growth; regulatory clarifications on acceptable dosage forms and palatability claims provide clearer compliance pathways. Advances in flavor technology (microencapsulation, controlled release) allow flavor longevity and safety, enabling products suitable for chronic therapies and long-term dosing-making palatability innovation a central growth driver.

Key constraints include regulatory scrutiny over permitted flavoring compounds, excipient residues and impacts on human food safety, requiring companies to balance innovation with compliance costs disclosed in annual reports. Flavor-excipient interactions can affect drug stability and bioavailability, necessitating costly compatibility and toxicology studies. Regulatory ambiguity between prescription and compounded products, and tighter oversight on compounding, can disrupt small compounding pharmacies and veterinary compounding models. Finally, competition from established animal-health majors and specialized flavor suppliers can compress margins for smaller players.

On the downstream side, demand is shifting from purely functional palatability to context-driven and service-oriented needs: pet owners and veterinarians want convenient administration, stress reduction, and home-care suitability. This drives demand for convenient dosage forms (single-use oral strips, chewables, ready-to-use liquids), diversified flavor portfolios, and tailored solutions for age, breed and preference. Food-safety and public-health considerations also propel the livestock sector to seek safe, mixable flavoring solutions that balance palatability with residue control. Clinical guidelines and strategic commitments in corporate annual reports point to increasing demand for standardized, scalable flavored veterinary products.

Key upstream inputs include natural or synthetic flavor compounds, sweeteners and taste-masking agents, textural excipients and binders, as well as carriers and stabilizers compatible with active pharmaceutical ingredients. Challenges include ensuring physicochemical compatibility, stability and toxicological safety of flavor materials with actives; supply risks arise from raw-material variability, supplier concentration and import/export controls (notably for natural extracts). Sustainability and responsible sourcing matter-natural flavor feedstocks can be climate-sensitive, while synthetic alternatives must meet safety and acceptance thresholds. Leading animal-health companies highlight in annual reports the critical importance of supplier qualification, raw-material traceability and GMP-grade excipient sourcing-factors that elevate both cost and market entry barriers.The gross profit margin of this product is around 55%.

This report aims to provide a comprehensive presentation of the global market for Flavored Veterinary Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Flavored Veterinary Medication by region & country, by Type, and by Application.

The Flavored Veterinary Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flavored Veterinary Medication.

Market Segmentation

By Company

  • Boehringer Ingelheim
  • Elanco Animal Health
  • Zoetis
  • Merck & Co.
  • Ceva
  • Vetoquinol
  • Wedgewood Pharmacy
  • Virbac
  • BOVA
  • Lee Silsby Compounding Pharmacy
  • Golden Gate
  • China Animal Healthcare
  • Qingdao Yibang
  • Rupu Bio

Segment by Type

  • Meat Flavored
  • Fish Flavored
  • Fruit Flavored
  • Others

Segment by Application

  • Dogs
  • Cats
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Flavored Veterinary Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Flavored Veterinary Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Flavored Veterinary Medication in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Flavored Veterinary Medication Product Introduction
  • 1.2 Global Flavored Veterinary Medication Market Size Forecast (2020-2031)
  • 1.3 Flavored Veterinary Medication Market Trends & Drivers
    • 1.3.1 Flavored Veterinary Medication Industry Trends
    • 1.3.2 Flavored Veterinary Medication Market Drivers & Opportunity
    • 1.3.3 Flavored Veterinary Medication Market Challenges
    • 1.3.4 Flavored Veterinary Medication Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Flavored Veterinary Medication Players Revenue Ranking (2024)
  • 2.2 Global Flavored Veterinary Medication Revenue by Company (2020-2025)
  • 2.3 Key Companies Flavored Veterinary Medication Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Flavored Veterinary Medication Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Flavored Veterinary Medication
  • 2.6 Flavored Veterinary Medication Market Competitive Analysis
    • 2.6.1 Flavored Veterinary Medication Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Flavored Veterinary Medication Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flavored Veterinary Medication as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Meat Flavored
    • 3.1.2 Fish Flavored
    • 3.1.3 Fruit Flavored
    • 3.1.4 Others
  • 3.2 Global Flavored Veterinary Medication Sales Value by Type
    • 3.2.1 Global Flavored Veterinary Medication Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Flavored Veterinary Medication Sales Value, by Type (2020-2031)
    • 3.2.3 Global Flavored Veterinary Medication Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Dogs
    • 4.1.2 Cats
    • 4.1.3 Other
  • 4.2 Global Flavored Veterinary Medication Sales Value by Application
    • 4.2.1 Global Flavored Veterinary Medication Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Flavored Veterinary Medication Sales Value, by Application (2020-2031)
    • 4.2.3 Global Flavored Veterinary Medication Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Flavored Veterinary Medication Sales Value by Region
    • 5.1.1 Global Flavored Veterinary Medication Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Flavored Veterinary Medication Sales Value by Region (2020-2025)
    • 5.1.3 Global Flavored Veterinary Medication Sales Value by Region (2026-2031)
    • 5.1.4 Global Flavored Veterinary Medication Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.2.2 North America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.3.2 Europe Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Flavored Veterinary Medication Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.5.2 South America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Flavored Veterinary Medication Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Flavored Veterinary Medication Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.3.2 United States Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.4.2 Europe Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.5.2 China Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.6.2 Japan Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.7.2 South Korea Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.9.2 India Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boehringer Ingelheim
    • 7.1.1 Boehringer Ingelheim Profile
    • 7.1.2 Boehringer Ingelheim Main Business
    • 7.1.3 Boehringer Ingelheim Flavored Veterinary Medication Products, Services and Solutions
    • 7.1.4 Boehringer Ingelheim Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Boehringer Ingelheim Recent Developments
  • 7.2 Elanco Animal Health
    • 7.2.1 Elanco Animal Health Profile
    • 7.2.2 Elanco Animal Health Main Business
    • 7.2.3 Elanco Animal Health Flavored Veterinary Medication Products, Services and Solutions
    • 7.2.4 Elanco Animal Health Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Elanco Animal Health Recent Developments
  • 7.3 Zoetis
    • 7.3.1 Zoetis Profile
    • 7.3.2 Zoetis Main Business
    • 7.3.3 Zoetis Flavored Veterinary Medication Products, Services and Solutions
    • 7.3.4 Zoetis Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Zoetis Recent Developments
  • 7.4 Merck & Co.
    • 7.4.1 Merck & Co. Profile
    • 7.4.2 Merck & Co. Main Business
    • 7.4.3 Merck & Co. Flavored Veterinary Medication Products, Services and Solutions
    • 7.4.4 Merck & Co. Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Merck & Co. Recent Developments
  • 7.5 Ceva
    • 7.5.1 Ceva Profile
    • 7.5.2 Ceva Main Business
    • 7.5.3 Ceva Flavored Veterinary Medication Products, Services and Solutions
    • 7.5.4 Ceva Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Ceva Recent Developments
  • 7.6 Vetoquinol
    • 7.6.1 Vetoquinol Profile
    • 7.6.2 Vetoquinol Main Business
    • 7.6.3 Vetoquinol Flavored Veterinary Medication Products, Services and Solutions
    • 7.6.4 Vetoquinol Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Vetoquinol Recent Developments
  • 7.7 Wedgewood Pharmacy
    • 7.7.1 Wedgewood Pharmacy Profile
    • 7.7.2 Wedgewood Pharmacy Main Business
    • 7.7.3 Wedgewood Pharmacy Flavored Veterinary Medication Products, Services and Solutions
    • 7.7.4 Wedgewood Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Wedgewood Pharmacy Recent Developments
  • 7.8 Virbac
    • 7.8.1 Virbac Profile
    • 7.8.2 Virbac Main Business
    • 7.8.3 Virbac Flavored Veterinary Medication Products, Services and Solutions
    • 7.8.4 Virbac Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Virbac Recent Developments
  • 7.9 BOVA
    • 7.9.1 BOVA Profile
    • 7.9.2 BOVA Main Business
    • 7.9.3 BOVA Flavored Veterinary Medication Products, Services and Solutions
    • 7.9.4 BOVA Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.9.5 BOVA Recent Developments
  • 7.10 Lee Silsby Compounding Pharmacy
    • 7.10.1 Lee Silsby Compounding Pharmacy Profile
    • 7.10.2 Lee Silsby Compounding Pharmacy Main Business
    • 7.10.3 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Products, Services and Solutions
    • 7.10.4 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Lee Silsby Compounding Pharmacy Recent Developments
  • 7.11 Golden Gate
    • 7.11.1 Golden Gate Profile
    • 7.11.2 Golden Gate Main Business
    • 7.11.3 Golden Gate Flavored Veterinary Medication Products, Services and Solutions
    • 7.11.4 Golden Gate Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Golden Gate Recent Developments
  • 7.12 China Animal Healthcare
    • 7.12.1 China Animal Healthcare Profile
    • 7.12.2 China Animal Healthcare Main Business
    • 7.12.3 China Animal Healthcare Flavored Veterinary Medication Products, Services and Solutions
    • 7.12.4 China Animal Healthcare Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.12.5 China Animal Healthcare Recent Developments
  • 7.13 Qingdao Yibang
    • 7.13.1 Qingdao Yibang Profile
    • 7.13.2 Qingdao Yibang Main Business
    • 7.13.3 Qingdao Yibang Flavored Veterinary Medication Products, Services and Solutions
    • 7.13.4 Qingdao Yibang Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Qingdao Yibang Recent Developments
  • 7.14 Rupu Bio
    • 7.14.1 Rupu Bio Profile
    • 7.14.2 Rupu Bio Main Business
    • 7.14.3 Rupu Bio Flavored Veterinary Medication Products, Services and Solutions
    • 7.14.4 Rupu Bio Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Rupu Bio Recent Developments

8 Industry Chain Analysis

  • 8.1 Flavored Veterinary Medication Industrial Chain
  • 8.2 Flavored Veterinary Medication Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Flavored Veterinary Medication Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Flavored Veterinary Medication Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제